Advertisement
Advertisement
CDXS
Codexis, Inc.
2.85
USDSponsored
+0.27
+10.47%
May 08, 15:59 UTC -4
Closed
After-Market
2.85
0.00
-0.14%
CDXS Earnings Reports
Positive Surprise Ratio
CDXS beat 27 of 42 last estimates.
64%
Next Report
Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$16.07M
/-$0.12
Implied change from Q1 26 (Revenue/ EPS)
+5.41%
/+20.00%
Implied change from Q2 25 (Revenue/ EPS)
+4.87%
/-25.00%
Codexis, Inc. earnings per share and revenue
On May 07, 2026, CDXS reported earnings of -0.10 USD per share (EPS) for Q1 26, beating the estimate of -0.13 USD, resulting in a 28.26% surprise. Revenue reached 15.25 million, compared to an expected 14.82 million, with a 2.93% difference. The market reacted with a +10.47% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 16.07 million USD, implying an increase of 20.00% EPS, and increase of 5.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Iovance Biotherapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.19
Surprise
-24.35%
Corvus Pharmaceuticals, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.15
Surprise
-2.95%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
Ginkgo Bioworks Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.09
Actual
-$1.28
Surprise
-17.35%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
PTC Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.47
Actual
-$0.03
Surprise
+93.75%
Scholar Rock Holding Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.81
Actual
-$0.83
Surprise
-1.62%
Aligos Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$2.26
Actual
-$2.21
Surprise
+2.54%
FAQ
What were Codexis, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Codexis, Inc. reported EPS of -$0.10, beating estimates by 28.26%, and revenue of $15.25M, 2.93% above expectations.
How did the market react to Codexis, Inc.'s Q1 2026 earnings?
The stock price moved up 10.47%, changed from $2.58 before the earnings release to $2.85 the day after.
When is Codexis, Inc. expected to report next?
The next earning report is scheduled for Aug 11, 2026.
What are the forecasts for Codexis, Inc.'s next earnings report?
Based on 7
analysts, Codexis, Inc. is expected to report EPS of -$0.12 and revenue of $16.07M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement